Qualcomm and Arm Return to Court in High-Stakes Legal Clash Over Chip Licenses and Tools

Key facts

According to reporting by CNA, the trial that began on Monday brings Qualcomm and Arm back before a judge and jury in Delaware to resolve severe claims of contract violation. Qualcomm's legal team contends that Arm failed to deliver specialized chip testing tools that Qualcomm was contractually owed under their existing technical agreements. These testing tools are vital software utilities used by semiconductor engineers to verify, simulate, and validate custom processor core designs against Arm’s instruction set architecture before sending designs to commercial foundries for mass fabrication.

Qualcomm further alleges that Arm engaged in unfair tactics by leaking confidential corporate actions to news outlets, according to CNA's reporting. Specifically, Qualcomm claims that Arm publicized its 2024 threat to revoke Qualcomm’s broad architectural license agreement. By disclosing this threat to the media, Qualcomm argues Arm sought to create public uncertainty around Qualcomm’s product roadmap, pressure company executives, and destabilize customer confidence in Qualcomm’s long-term hardware offerings.

Arm has historically disputed Qualcomm's claims, arguing that Qualcomm violated the terms of its original licensing agreements by incorporating customized compute core designs derived from third-party acquisitions without renegotiating royalty rates and transfer permissions. The Delaware trial will examine the specific breach-of-contract allegations regarding tool withholding and media disclosures, with significant financial compensation hanging in the balance.

Why it matters

The courtroom confrontation in Delaware carries profound ramifications for the broader electronics ecosystem, corporate licensing practices, and semiconductor supply chains worldwide. Arm does not manufacture physical silicon chips; instead, it licenses its instruction set architecture (ISA) and pre-designed compute cores to major technology companies. Qualcomm, one of Arm's largest customers, uses these architectural rights to design processors that power hundreds of millions of Android smartphones, premium laptops, automotive infotainment systems, and internet-of-things devices.

If the court finds Arm liable for withholding essential design and testing tools, Qualcomm could be awarded massive financial damages to offset project delays, extra engineering expenditures, and commercial disruptions. Conversely, if the litigation exposes broader vulnerabilities in Qualcomm's right to utilize Arm architecture, hardware manufacturers that rely on Qualcomm chips could face supply chain uncertainty.

Beyond the immediate dispute between these two companies, the case sets a critical legal precedent for the semiconductor industry regarding architectural licensing agreements (ALAs). As tech firms increasingly build custom silicon to meet the demanding requirements of artificial intelligence and high-performance computing, the boundaries between proprietary custom design and standard architecture licensing remain central to corporate valuations and market stability.

The relationship between Qualcomm, based in San Diego, California, and Arm Holdings, based in Cambridge, England, has deteriorated over several years of complex commercial friction. Historically, chip designers had two primary options when working with Arm: license ready-made CPU cores under a Technology License Agreement (TLA) or purchase an Architectural License Agreement (ALA), which allows companies to build their own custom CPU cores from scratch as long as they adhere to the Arm instruction set standard.

The legal feud intensified dramatically following Qualcomm’s $1.4 billion acquisition of chip design startup Nuvia Inc. in 2021. Nuvia, founded by former Apple processor architects, held its own custom architectural license with Arm to develop high-performance server and PC CPUs. Qualcomm integrated Nuvia’s engineering team and custom architecture into its internal roadmap to create its custom Oryon CPU cores, which now power its latest Snapdragon mobile platforms and Snapdragon X Elite PC processors.

In 2022, Arm filed a lawsuit against Qualcomm in Delaware federal court, asserting that Nuvia’s Arm licenses were non-transferable without Arm’s express consent. Arm argued that Qualcomm was required to destroy Nuvia-derived designs created before the acquisition or negotiate new, higher royalty rates. Qualcomm counter-claimed that its pre-existing enterprise architectural license already covered all custom core development across its subsidiaries.

The conflict reached a new peak in late 2024 when Arm issued a formal 60-day notice of intent to cancel Qualcomm’s overall architectural license agreement. That maneuver, which Qualcomm now alleges was improperly leaked to media outlets, posed an existential challenge to Qualcomm’s core chip business. Although both companies continued operating under temporary agreements while court dates were scheduled, the dispute has remained an unresolved risk hanging over the global tech market.

Reaction

Neither Qualcomm nor Arm Holdings issued detailed formal statements on the trial's opening day beyond their filed court documents, according to reporting by CNA. However, the legal proceedings have drawn intensive monitoring across global financial markets and technology sectors.

Wall Street equity analysts covering Arm Holdings (NASDAQ: ARM) and Qualcomm Inc. (NASDAQ: QCOM) have highlighted the case as a major volatility factor for both stocks. Financial institutions note that a prolonged legal rift could compel Qualcomm to explore alternative, open-source instruction set architectures like RISC-V for future processor generations, which would jeopardize Arm’s long-term royalty revenue streams.

Major original equipment manufacturers (OEMs)—including smartphone leaders like Samsung and PC makers such as Microsoft, Dell, Lenovo, and HP—are following the trial closely. Industry analysts expect trade associations and technology standards groups to closely review any rulings that affect the enforceability of standardized technical cross-licensing contracts.

What we don't know yet

Several pivotal details regarding the trial and its broader consequences remain unverified:

What to watch

As the court proceedings move forward in Wilmington, several concrete developments will determine the ultimate trajectory of the dispute:

This report is based on original news coverage provided by CNA.